Document is current

Any future updates will be listed below

Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis

Crossref DOI link: https://doi.org/10.1007/s12325-017-0628-2

Published Online: 2017-10-26

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark